# Novel Brain Neurotechnology for Optimizing Precision Mirror Therapy in Stroke

Study · id `cardio:ct-nct05238272` · Cardiovascular Atlas · release `a25293eeae6350fb` (public)

> General information from published sources, not medical advice, and not reviewed by clinicians. Check the cited source before relying on anything here. Sponsors do not influence what this atlas says.

The atlas's own text and curation may be reused under Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0, https://creativecommons.org/licenses/by-nc/4.0/): credit the atlas, and do not use it commercially without a licence from the owner. See the atlas About page. Text quoted from a source stays under that source's own terms, given as the source's reuse\_basis. The atlas's reuse terms do not cover it. The downloads list each quotation with its source in third\_party\_quotations.

**Registry record.** Assembled by a program from [ClinicalTrials.gov record NCT05238272](<https://clinicaltrials.gov/study/NCT05238272>), retrieved 26 October 2026. No person wrote or checked this page.

Also called: NCT05238272

Browse, organ or system: Brain  
Browse, condition area: Stroke  

## In plain language

A trial with no phase registered on ClinicalTrials.gov. The registry status is recruiting. It plans to enroll 128 participants.

## Technical summary

Registry record NCT05238272. Randomized; double masking; primary purpose treatment. Start 2022-03-01 (anticipated); primary completion 2026-12-31 (anticipated). Results not posted.

## Key facts

- Design: Interventional study; randomized; double masking; primary purpose treatment
- Phase: Not applicable
- Enrolled: 128 participants (planned count; ClinicalTrials.gov record NCT05238272, source copy `cardio:ctgov-nct05238272-2022-02-14`, retrieved 2026-10-26)
- Planned start: 2022-03-01 (anticipated) (ClinicalTrials.gov record NCT05238272, source copy `cardio:ctgov-nct05238272-2022-02-14`, retrieved 2026-10-26)
- Primary completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05238272, source copy `cardio:ctgov-nct05238272-2022-02-14`, retrieved 2026-10-26)
- Completion: 2026-12-31 (anticipated) (ClinicalTrials.gov record NCT05238272, source copy `cardio:ctgov-nct05238272-2022-02-14`, retrieved 2026-10-26)
- Countries: Taiwan (ClinicalTrials.gov record NCT05238272, source copy `cardio:ctgov-nct05238272-2022-02-14`, retrieved 2026-10-26)
- Care setting: Not reported
- Registry status: "RECRUITING" (U.S. National Library of Medicine (ClinicalTrials.gov), source copy `cardio:ctgov-nct05238272-2022-02-14`, retrieved 2026-10-26)

## The registry's words

- Brief title: Novel Brain Neurotechnology for Optimizing Precision Mirror Therapy in Stroke
- Condition: Cerebrovascular Accident
- Intervention (Device): Transcranial random noise stimulation (tRNS)
- Intervention (Device): sham tRNS
- Intervention (Behavioral): the unilateral MT
- Intervention (Behavioral): the bilateral MT
- Lead sponsor: Chang Gung Memorial Hospital
- Lead sponsor class: OTHER

## Connected pages

- Registry condition terms include this condition: Stroke (`core:stroke`)
- Registry lists this organization as the lead sponsor: Chang Gung Memorial Hospital (`cardio:org-chang-gung-memorial-hospital`)

## Provenance

Content hash: 6aa17554f97e9c3ede93106471af4e12c8809f5d313f69058fb22b2e8cd6005c
Last substantive edit: 2026-11-08
Evidence last checked: Not recorded
